Lyme Disease Diagnostic Personalization
Lyme disease
ResearchActive
Key Facts
About Innatoss Laboratories
Innatoss Laboratories is a Dutch diagnostic company founded in 2014, specializing in challenging infectious diseases like Lyme, Q fever, and COVID-19. Its core strategy involves smartly utilizing or developing new immunological tests to improve diagnostic accuracy and speed, thereby aiming to prevent chronic conditions. The company engages in both commercial testing services and collaborative research with academic and patient organizations, positioning itself as a niche expert in a difficult diagnostic segment.
View full company profileTherapeutic Areas
Other Lyme disease Drugs
| Drug | Company | Phase |
|---|---|---|
| VLA15 | Valneva | Phase 3 |
| Lyme Disease and Coinfections Diagnostics | Fry Laboratories | Commercial |
| Lyme Disease Diagnostic | BlueArc Biosciences | Research/Proof-of-Concept |
| Lyme Disease Vaccine | CyanVac | Preclinical |
| Next-Gen Lyme Test | Kephera Diagnostics | Development/Validation |